AI & Machine Learning

After conquering football, Scorability is expanding to seven new sports, leveraging AI and "mentality assessments" to change how colleges find talent.

The AI-ed-tech firm just erased 22% of its public float. Is this a masterstroke in shareholder value or a desperate move to mask underlying issues?

At a Paris defense expo, a new autonomous ground vehicle debuts with a bold promise: to see, navigate, and fight in total electronic silence.

A new D.C. boutique law firm is making waves by poaching top SEC talent and a veteran tech lawyer. Here’s the inside story on a strategic talent grab.

As the National Center for Manufacturing Sciences marks four decades, its unique partnership with the DoD offers a masterclass in accelerating technology.

Rare complete responses in deadly pancreatic cancer hint at a powerful new synergy, but can Elicio Therapeutics secure the funding to prove its theory?

In an age of AI and deepfakes, a new book argues that authentic human influence is the ultimate competitive advantage. Here’s why every leader must master it.

With 911 centers facing staff shortages and burnout, Intrado is betting on AI to help. Can new tech ease the burden without losing the human touch?

WAGMI Game Co. is embedding NFC chips in its NiFe WARS comics, creating a digital twin to fight counterfeits and deepen fan engagement. Is this the future?

Lakeside Software's high rank on TIME's new WorkTech list isn't just an award. It signals a shift where proactive IT and employee digital well-being are key to success.

Autonomous systems firm INDROTEK signals its IPO ambitions by hiring a strategic communications partner, revealing a plan to master both AI robotics and investor trust.

At Automate 2026's first Humanoid Pavilion, Richtech Robotics showcases its DEX robot. Is this the tipping point for human-robot collaboration in industry?

A new report reveals AI isn't the problem in finance; it's the data. Weak foundations are costing firms billions and exposing a critical industry blind spot.

A new survey reveals 72% of firms run AI agents with unmanaged risk. As authority outpaces control, businesses face revenue loss and untraceable failures.

Forget costly new robots. A new partnership lets companies upgrade existing carts with smart wheels, revolutionizing logistics in complex, space-constrained facilities.

Insilico Medicine's AI-designed drug, ISM8969, enters human trials, targeting chronic neuroinflammation by crossing the elusive blood-brain barrier.

A single Bitcoin wager in Las Vegas just changed the game. How a new partnership is finally making crypto useful, legal, and a core part of commerce.

As tech IPOs stall, a new breed of private credit fund offers a lifeline to employees with 'paper wealth,' unlocking billions in value from top unicorns.

As AI agents gain autonomy, the risk of breaches soars. WitnessAI's new Agentic Control offers a single control plane to tame these digital workers.

With a key regulatory win in the UAE, WAT Medical is set to introduce its drug-free neuromodulation devices to a booming Middle Eastern healthcare market.